Jacquelot Nicolas, Enot David P, Flament Caroline, Vimond Nadège, Blattner Carolin, Pitt Jonathan M, Yamazaki Takahiro, Roberti María Paula, Daillère Romain, Vétizou Marie, Poirier-Colame Vichnou, Semeraro Michaëla, Caignard Anne, Slingluff Craig L, Sallusto Federica, Rusakiewicz Sylvie, Weide Benjamin, Marabelle Aurélien, Kohrt Holbrook, Dalle Stéphane, Cavalcanti Andréa, Kroemer Guido, Di Giacomo Anna Maria, Maio Michele, Wong Phillip, Yuan Jianda, Wolchok Jedd, Umansky Viktor, Eggermont Alexander, Zitvogel Laurence
J Clin Invest. 2016 Mar 1;126(3):921-37. doi: 10.1172/JCI80071. Epub 2016 Feb 8.
Melanoma prognosis is dictated by tumor-infiltrating lymphocytes, the migratory and functional behavior of which is guided by chemokine or cytokine gradients. Here, we retrospectively analyzed the expression patterns of 9 homing receptors (CCR/CXCR) in naive and memory CD4+ and CD8+ T lymphocytes in 57 patients with metastatic melanoma (MMel) with various sites of metastases to evaluate whether T cell CCR/CXCR expression correlates with intratumoral accumulation, metastatic progression, and/or overall survival (OS). Homing receptor expression on lymphocytes strongly correlated with MMel dissemination. Loss of CCR6 or CXCR3, but not cutaneous lymphocyte antigen (CLA), on circulating T cell subsets was associated with skin or lymph node metastases, loss of CXCR4, CXCR5, and CCR9 corresponded with lung involvement, and a rise in CCR10 or CD103 was associated with widespread dissemination. High frequencies of CD8+CCR9+ naive T cells correlated with prolonged OS, while neutralizing the CCR9/CCL25 axis in mice stimulated tumor progression. The expansion of CLA-expressing effector memory CD8+ T cells in response to a single administration of CTLA4 blockade predicted disease control at 3 months in 47 patients with MMel. Thus, specific CCR/CXCR expression patterns on circulating T lymphocytes may guide potential diagnostic and therapeutic approaches.
黑色素瘤的预后由肿瘤浸润淋巴细胞决定,其迁移和功能行为受趋化因子或细胞因子梯度引导。在此,我们回顾性分析了57例有不同转移部位的转移性黑色素瘤(MMel)患者中,初始和记忆性CD4⁺和CD8⁺T淋巴细胞中9种归巢受体(CCR/CXCR)的表达模式,以评估T细胞CCR/CXCR表达是否与肿瘤内聚集、转移进展和/或总生存期(OS)相关。淋巴细胞上归巢受体的表达与MMel的播散密切相关。循环T细胞亚群上CCR6或CXCR3的缺失,但不是皮肤淋巴细胞抗原(CLA)的缺失,与皮肤或淋巴结转移相关;CXCR4、CXCR5和CCR9的缺失与肺受累相关;CCR10或CD103的升高与广泛播散相关。高频率的CD8⁺CCR9⁺初始T细胞与延长的OS相关联,而在小鼠中中和CCR9/CCL25轴会促进肿瘤进展。在47例MMel患者中,单次给予CTLA4阻断后,表达CLA的效应记忆性CD8⁺T细胞的扩增预示着3个月时的疾病控制。因此,循环T淋巴细胞上特定的CCR/CXCR表达模式可能指导潜在的诊断和治疗方法。